Stay updated with breaking news from Ben Brahim. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New Data Showing that Transgene and NEC's Individualized Cancer Vaccine TG4050 Induces Strong and Specific Immune Responses against Tumors Presented at AACR 2023 - New Phase I data confirm promising immunogenicity and efficacy profile of TG4050, an ...
New Phase I data confirm promising immunogenicity and efficacy profile of TG4050, an individualized neoantigen cancer vaccine developed by Transgene in collaboration with NEC Corporation In the head
Invir.IO® based oncolytic virus TG6050, is armed with IL-12 and an anti-CTLA4 antibody. A Phase I trial (Delivir) recently started enrolling patients with advanced non-small cell lung cancer (NSCLC)
Invir.IO® based oncolytic virus TG6050, is armed with IL-12 and an anti-CTLA4 antibody. A Phase I trial (Delivir) recently started enrolling patients with advanced non-small cell lung cancer (NSCLC)STRASBOURG, France--(BUSINESS WIRE)--#HBV--Regulatory News:Transgene (Euronext Paris: TNG), a biotech company that desi...
KPK names Kapuas Regent Ben Brahim S. Bahat and his wife who is a member of the parliament suspects as suspects for allegedly extorting civil servants